ClinicalTrials.govpublic full text
A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma
non-hodgkin lymphoma, dlbcl, diffuse large b-cell lymphoma, grade 3 follicular lymphoma, antibody-drug conjugate, cd19, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893417
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.